Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X8SY
|
|||
| Former ID |
DIB016183
|
|||
| Drug Name |
Oxazyme
|
|||
| Synonyms |
SCHEMBL6508464; BDBM92490; IxC1-62/47; Recombinant oxalate degrading enzyme (oral, hyperoxaluria), OxThera; Recombinant oxalate degrading enzyme (oral, hyperoxaluria), Q-Med/ Ixion Biotechnology
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hyperoxaluria [ICD-11: 5C51.2] | Phase 1/2 | [1] | |
| Company |
University of Florida
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H15BrN4O
|
|||
| Canonical SMILES |
CC1=C2C(=NN1)C3=C(C=CC(=C3)Br)N(C2=O)CCCN
|
|||
| InChI |
1S/C14H15BrN4O/c1-8-12-13(18-17-8)10-7-9(15)3-4-11(10)19(14(12)20)6-2-5-16/h3-4,7H,2,5-6,16H2,1H3,(H,17,18)
|
|||
| InChIKey |
LLKFNPUXQZHIAE-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01127087) Oxazyme in Patients With Hyperoxaluria. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.